Sumi, Hitoshi
Hoshiyama, Tadashi
Morihisa, Kenji
Noda, Katsuo
Kaneko, Shozo
Kanazawa, Hisanori
Ishii, Masanobu
Fujisue, Koichiro
Sueta, Daisuke
Takashio, Seiji
Usuku, Hiroki
Matsushita, Kenichi
Tsujita, Kenichi
Funding for this research was provided by:
J & J Medical Research Grant
Article History
Received: 13 September 2022
Accepted: 9 February 2023
First Online: 13 February 2023
Competing interests
: Dr Tsujita has received significant research grant from AMI Co., Ltd., Bayer Yakuhin, Ltd., Bristol-Myers K.K., EA Pharma Co., Ltd., MOCHIDA PHARMACEUTICAL CO., LTD., and scholarship fund from AMI Co., Ltd., Bayer Yakuhin, Ltd., Boehringer Ingelheim Japan, Chugai Pharmaceutical Co, Ltd., Daiichi Sankyo Co., Ltd., Edwards Lifesciences Corporation, Johnson & Johnson K.K., ONO PHARMACEUTICAL CO., LTD., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and honoraria from Amgen K.K., Bayer Yakuhin, Ltd., Daiichi Sankyo Co., Ltd., Kowa Pharmaceutical Co. Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., and belongs to the endowed departments donated by Abbott Japan Co., Ltd., Boston Scientific Japan K.K., Fides-one, Inc., GM Medical Co., Ltd., ITI Co., Ltd., Kaneka Medix Co., Ltd., NIPRO CORPORATION, TERUMO Co, Ltd., Abbott Medical Co., Ltd., Cardinal Health Japan, Fukuda Denshi Co., Ltd., Japan Lifeline Co., Ltd., Medical Appliance Co., Ltd., Medtronic Japan Co., Ltd. There are no conflict of interest related to this present study among the other authors.